Journal article 1055 views 112 downloads
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
,
Xiucui Ma,
Sheng Shen,
Maria Florencia Gomez Castro,
Zhuoming Liu,
Qiru Zeng,
Haiyan Zhao,
Juhee Son,
Paul W. Rothlauf,
Alex J. B. Kreutzberger,
Gaopeng Hou,
Hu Zhang,
Sayantan Bose,
Xin Wang,
Michael D. Vahey,
Kartik Mani,
William Griffiths ,
Tom Kirchhausen,
Daved H. Fremont,
Haitao Guo,
Abhinav Diwan,
Yuqin Wang ,
Michael S. Diamond,
Sean P. J. Whelan,
Siyuan Ding
Proceedings of the National Academy of Sciences, Volume: 117, Issue: 50, Pages: 32105 - 32113
Swansea University Authors:
Eylan Yutuc , William Griffiths , Yuqin Wang
-
PDF | Version of Record
This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).
Download (1.41MB)
DOI (Published version): 10.1073/pnas.2012197117
Abstract
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiological agent of coronavirus disease-2019 (COVID-19), has swept the world in unprecedented speed. In a few months, SARS-CoV-2 has infected millions of people and caused tens of thousands of deaths. There are no Food and...
| Published in: | Proceedings of the National Academy of Sciences |
|---|---|
| ISSN: | 0027-8424 1091-6490 |
| Published: |
Proceedings of the National Academy of Sciences
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa55583 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiological agent of coronavirus disease-2019 (COVID-19), has swept the world in unprecedented speed. In a few months, SARS-CoV-2 has infected millions of people and caused tens of thousands of deaths. There are no Food and Drug Administration-approved antivirals or vaccines yet available and clinical treatments are limited to supportive therapies that help alleviate the symptoms. Thus, there is an urgent need to identify effective antivirals as countermeasures before safe and effective vaccines are developed, tested, and then produced on a large scale. Our approach is to harness the germline-encoded interferon antiviral response to inhibit SARS-CoV-2 replication thereby limiting its pathogenicity |
|---|---|
| Keywords: |
SARS-CoV-2; interferon; virus entry; COVID-19; innate immunity |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
50 |
| Start Page: |
32105 |
| End Page: |
32113 |